TC BioPharm, a Scottish biotech firm, has won approval to test an experimental T-cell injection therapy to fight COVID-19 by boosting the immune system early in a coronavirus infection, the Financial Times reports. The six-month trial in Edinburgh will involve harvesting T-cells from healthy people, cultivating a large number of the cells in a lab, then injecting the donor cells into hospitalized patients. A large enough infusion could head off the infection before the patient needs to move to intensive care, and even prevent cytokine storms that ravage patients whose body mounts an overly aggressive immune response.
"We have got some evidence that if you kill the virus effectively early on, then [there] should be no reason for the host to have this overwhelming response," Dr. Nik HiraniNik Hirani at Edinburgh University's Center for Inflammation Research tells FT. TC BioPharm founder and CEO Mike Leek said the trial will focus on gamma delta T-cells, the "bully boys" of the immune system. "They circulate in surveillance mode looking for a fight and are in particular attracted to cells that are stressed either by cancer or viral infection, for which they are our first line of defense," he said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Today's political cartoons - November 23, 2024Cartoons Saturday's cartoons - qualifications, tax cuts, and more
-
Long summer days in Iceland's highlandsThe Week Recommends While many parts of this volcanic island are barren, there is a 'desolate beauty' to be found in every corner
-
The Democrats: time for wholesale reform?Talking Point In the 'wreckage' of the election, the party must decide how to rebuild
-
US charges Indian tycoon with bribery, fraudSpeed Read Indian billionaire Gautam Adani has been indicted by US prosecutors for his role in a $265 million scheme to secure solar energy deals
-
Boeing machinists approve contract, end strikeSpeed Read The company's largest union approved the new contract offer, ending a seven-week strike
-
US economy still strong in final preelection reportSpeed Read It grew at a solid 2.8% annual rate from July through September
-
Boeing machinists reject deal, continue strikeSpeed Read The rejection came the same day Boeing reported a $6.2 billion quarterly loss
-
Ports reopen after dockworkers halt strikeSpeed Read The 36 ports that closed this week, from Maine to Texas, will start reopening today
-
Empty-nest boomers aren't selling their big homesSpeed Read Most Americans 60 and older do not intend to move, according to a recent survey
-
Brazil accuses Musk of 'disinformation campaign'Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
-
Disney board fends off Peltz infiltration bidSpeed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
